Global Preventive Asthma Drugs Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

Segmented by Class Of Drugs;

Immunosuppressants , Leukotriene antagonists, Mast cell stabilizers, Corticosteroids and Combination of LABA/ ICS.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2017 - 2027).
Report ID: Rn497799042 Published Date: December, 2021 Updated Date: January, 2022

Introduction

Global Preventive Asthma Drugs Market (USD Million), 2017 - 2027

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2017 - 2027
2017 95.2
2018 99.9
2019 104.5
2020 110.2
2021 111.1
2022 117.0
2023 117.5
2024 128.9
2025 134.9
2026 145.8
2027 153.3

In the year 2020, the Global Preventive Asthma Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Class Of Drugs
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Preventive Asthma Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. High prevalence of asthma
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Preventive Asthma Drugs Market, By Class Of Drugs, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. Immunosuppressants
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Leukotriene antagonists
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        3. Mast cell stabilizers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        4. Corticosteroids
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        5. Combination of LABA/ ICS
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    2. Global Preventive Asthma Drugs Market, By Geography, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Class Of Drugs, 2017 - 2027 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AstraZeneca
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. F. Hoffmann-La Roche
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. GlaxoSmithKline
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Merck
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Novartis
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Prils
Global Prils Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Prils Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Primary Aldosteronism
Global Primary Aldosteronism Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Primary Aldosteronism Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Primary Biliary Cholangitis (PBC) Therapeutics
Global Primary Biliary Cholangitis (PBC) Therapeutics Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Primary Biliary Cholangitis (PBC) Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Primary Ciliary Dyskinesia
Global Primary Ciliary Dyskinesia Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Primary Ciliary Dyskinesia Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...